Different effects of Bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (A 24-hour Holter Substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS])

American Journal of Cardiology

Volumn 83, Issue 8, 1999, Pages 1286-1289

  Anthonio, Rutger L ^a,b   Brouwer, Jan ^b   Lechat, Phillipe ^d   Haaksma, Jaap ^b   Van Der Ven, Louis ^c   Van Veldhuisen, Dirk J ^b   Crijns, Harry J G M ^b   Van Gilst, Wiek H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MERCK KGAA   (Germany)

^d Department of Pharmacology ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART FAILURE; HEART RATE; HOLTER MONITORING; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033560857     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00077-6     Document Type: Article

References (9)

1. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 90:1994;1765-1773.
2. Waagstein F., Bristow M.R., Swedberg K., Camerini F., Fowler M.B., Silver M.A., Gilbert E.M., Johnson M.R., Goss F.G., Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 342:1993;1441-1446.
3. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 334:1996;1349-1355.
4. Lechat P., Escolano S., Golmard J.L., Lardoux H., Witchitz S., Henneman J.A., Maisch B., Hetzel M., Jaillon P., Boissel J.P., et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation. 96:1997;2197-2205.
5. Copie X., Pousset F., Lechat P., Jaillon P., Guize L., Le Heuzey J.Y. Effects of beta-blockade with bisoprolol on heart rate variability in advanced heart failure analysis of scatterplots of R-R intervals at selected heart rates . Am Heart J. 132:1996;369-375.
6. Pousset F., Copie X., Lechat P., Jaillon P., Boissel J.P., Hetzel M., Fillette F., Remme W., Guize L., Le Heuzey J.Y. Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol. 77:1996;612-617.
7. Woodley S.L., Gilbert E.M., Anderson J.L., O'Connell J.B., Deitchman D., Yanowitz F.G., Mealey P.C., Volkman K., Renlund D.G., Menlove R., et al. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 84:1991;2426-2441.
8. Erlebacher J.A., Bhardwaj M., Suresh A., Leber G.B., Goldweit R.S. Beta-blocker treatment of idiopathic and ischemic dilated cardiomyopathy in patients with ejection fractions ≤20%. Am J Cardiol. 71:1993;1467-1469.
9. Andersson B., Blomstrom Lundqvist C, Hedner T., Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol. 18:1991;1059-1066.